Signaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S2623 Omecamtiv mecarbil (CK-1827452) <1 mg/mL 80 mg/mL 6 mg/mL
S7046 Brefeldin A <1 mg/mL 4 mg/mL <1 mg/mL
S7099 (-)-Blebbistatin <1 mg/mL 58 mg/mL <1 mg/mL
S2000 Sodium orthovanadate 36 mg/mL <1 mg/mL <1 mg/mL
S2528 Ciclopirox <1 mg/mL 42 mg/mL 42 mg/mL
S3628 BHQ <1 mg/mL 10 mg/mL 40 mg/mL
S3699 2,3-Butanedione-2-monoxime 20 mg/mL 20 mg/mL 20 mg/mL
S3019 Ciclopirox ethanolamine <1 mg/mL 6 mg/mL 30 mg/mL
S2233 Esomeprazole sodium 73 mg/mL 73 mg/mL 73 mg/mL
S7266 Golgicide A <1 mg/mL 57 mg/mL 4 mg/mL
S2222 PF-3716556 <1 mg/mL 79 mg/mL 79 mg/mL
S7460 BTB06584 <1 mg/mL 84 mg/mL <1 mg/mL
S8101 CB-5083 <1 mg/mL 82 mg/mL 13 mg/mL
S8276 FCCP <1 mg/mL 50 mg/mL 50 mg/mL
Catalog No. Information Product Use Citations Product Validations

Omecamtiv mecarbil (CK-1827452)

Omecamtiv mecarbil (CK-1827452) is a specific cardiac myosin activator and a clinical drug for left ventricular systolic heart failure. Phase 2.


Brefeldin A

Brefeldin A is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells, induces cancer cell differentiation and apoptosis.



(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM in cell-free assays, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly.


Sodium orthovanadate

Sodium orthovanadate is an alkaline phosphatase and (Na,K)-ATPase inhibitor with IC50 of 10 μM.



Ciclopirox is a broad-spectrum antifungal agent working as an iron chelator.



BHQ is a potent and selective inhibitor of the sarco-endoplasmic reticulum Ca2+-ATPase (SERCA).



2,3-Butanedione monoxime (BDM) is the well-characterized, low-affinity, non-competitive inhibitor of skeletal muscle myosin-II that inhibits skeletal and cardiac muscle contraction.


Ciclopirox ethanolamine

Ciclopirox ethanolamine (Ciclopirox olamine, HOE 296) is a broad-spectrum antifungal agent working as an iron chelator.


Esomeprazole sodium

Esomeprazole Sodium is a sodium salt of esomeprazole that is a potent proton pump inhibitor with an IC50 of 0.076 mg/kg.


Golgicide A

Golgicide A is a potent and rapidly reversible GBF1 inhibitor.



PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease.



BTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.



CB-5083 is a potent, selective, and orally bioavailable p97 AAA ATPase inhibitor with IC50 of 11 nM. Phase 1.



FCCP is a potent uncoupler of oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting protons across cell membranes.

Tags: ATPase inhibition | ATPase pump | ATPase activity | ATPase assay | sodium potassium ATPase pump | Na K-ATPase pump | Na K-ATPase activity | mitochondrial ATPase | Ca-ATPase pump | Na K-ATPase inhibition | myosin ATPase activity | H-ATPase pump | ATPase phosphorylation | ATPase assay protocol | HK-ATPase pump | Ca-ATPase activity | V-ATPase pump | sodium potassium ATPase activity | actomyosin ATPase activity | P-type ATPase pump